NEAUA 76th Annual Meeting, September 27 - 29, 2007, Seaport Hotel at the World Trade Center, Boston, Massachusetts

Preliminary Program

76th ANNUAL MEETING
September 27–29, 2007
Seaport Hotel at the World Trade Center, Boston, Massachusetts

 
THURSDAY, SEPTEMBER 27, 2007
10:00 a.m.-7:00 p.m.   REGISTRATION
3:00 p.m.-5:00 p.m.   HISTORY EXHIBIT
HANDS-ON SKILLS SESSIONS - Sign Up

Cityview Ballroom

Prosthetics in Urology, AMS
TBD

3:00 p.m.-7:00 p.m.   EXHIBIT HALL OPEN
Cityview Ballroom
5:00 p.m.-7:00 p.m.   WELCOME RECEPTION
Exhibit Hall, Cityview Ballroom
FRIDAY, SEPTEMBER 28, 2007
6:00 a.m.-7:50 a.m.  
BREAKFAST SYMPOSIUM
Harborview 2
   Breakfast Symposium: New Therapies in Managing Advanced Prostate Cancer

New Therapies in Managing Advanced Prostate Cancer

Faculty: Samir Taneja, MD
Associate Professor of Urology
New York University School of Medicine
New York, NY
Sam S. Chang, MD
Associate Professor
Vanderbilt University School of Medicine
Nashville, TN
Made possible by a grant from Watson Urology
7:00 a.m.-12:00 p.m.   EXHIBIT HALL OPEN
Cityview Ballroom
7:00 a.m.   CONTINENTAL BREAKFAST - VISIT EXHIBITS
Cityview Ballroom
8:00 a.m.   INTRODUCTION AND WELCOME
Amphitheater

W. Scott McDougal, MD, President
New England Section of the American Urological Association

Paul F. Schellhammer, MD, President
American Urological Association
8:15 a.m. - 9:50 a.m.   SCIENTIFIC SESSION I: PROSTATE CANCER
Amphitheater

Educational Objectives:
At the conclusion of this session the participants will be able to:
  • Describe the current areas of research in prostate cancer
  • List current areas of controversy in the management of prostate cancer
  • Describe the learning curve of robotic surgical techniques
8:15 a.m.   1. Long-term utilization of deferred treatment/watchful waiting as a long-term management option among men with prostate cancer in the Physicians’ Health Study
William V. Shappley, III, M.D.1, Julie L. Kasperzyk, F.M.2, Stacey A. Kenfield, ScD3, Lorelei A. Mucci, MPH, ScD3, Julia Fleet, B.A.4, Meir J. Stampfer, M.D., Dr.P.H.3, Jing Ma, M.D., PhD4, Martin G. Sanda, M.D.5.
1Brigham & Women's Hospital; Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Harvard School of Public Health, Boston, MA, USA, 3Brigham & Women's Hospital; Harvard School of Public Health, Boston, MA, USA, 4Brigham & Women's Hospital, Boston, MA, USA, 5Beth Israel Deaconess Medical Center, Boston, MA, USA.
8:22 a.m.   *2. Risk Factors Associated With Long-Term Retention of Prostate Cancer Patients in Watchful Waiting or Deferred Treatment Management without Progression to Definitive Intervention
William V. Shappley, III, M.D.1, Stacey A. Kenfield, ScD2, Julie L. Kasperzyk, F.M.3, June M. Chan, ScD4, Meir J. Stampfer, M.D., Dr.P.H.2, Martin G. Sanda, M.D.5.
1Brigham & Women's Hospital; Beth Israel Deaconess Medical Center, Boston, MA, USA, 2Brigham & Women's Hospital; Harvard School of Public Health, Boston, MA, USA, 3Harvard School of Public Health, Boston, MA, USA, 4University of California, San Francisco, San Francisco, CA, USA, 5Beth Israel Deaconess Medical Center, Boston, MA, USA.
8:29 a.m.   3. Active Surveillance Outcomes among Prostate Cancer Patients Diagnosed in the PSA Era
Barbara Ercole, MD, Sarah R. Marietti, Medical Doctor, Judith Fine, Peter C. Albertsen, Medical Doctor.
University of Connecticut, Farmington, CT, USA.
8:36 a.m.   4. Robotic Assisted Laparoscopic Prostatectomy: Learning Rate Analysis as an Objective Measure of Proficiency
Jesse Sammon, BHS1, Moritz Hansen, M.D.2, Lisa Beaule, M.D.2, Thomas Kinkead, M.D.2, Andrew Perry, BA3.
1University of New England College of Osteopathic Medicine, Biddeford, ME, USA, 2Portland Urologic Associates, Portland, ME, USA, 3Maine Medical Center, Portland, ME, USA.
8:43 a.m.   *5. The Cost of Learning Robotic-Assisted Prostatectomy
Peter L. Steinberg, MD, Paul A. Merguerian, MD, William Bihrle, III, MD, John D. Seigne, MB.
Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
8:50 a.m.   6. Robotic assisted radical prostatectomy: comparison of extraperitoneal and transperitoneal approaches during a single surgeon’s learning curve.
David Canes, MD, Maurizio S. Aragona, MD, Brasil S. Neto, MD, Alex J. Vanni, MD, Ingolf Tuerk, MD, PhD.
Lahey Clinic Medical Center, Boston, MA, USA.
8:57 a.m.   7. Primary Prostate Cryoablation: Results from the COLD Registry
Stephen M. Scionti, MD1, Bryan J. Donnelly, MD2, Aaron E. Katz, MD3, Louis L. Pisters, MD4, Franco M. Lugnani, MD5, John C. Rewcastle, PhD2, J. Stephen Jones, MD6.
1CryoCare Center, Hilton Head, SC, USA, 2University of Calgary, Calgary, AB, Canada, 3Columbia University, New York, NY, USA, 4MD Anderson Cancer Center, Houston, TX, USA, 5Society for Cryosurgery, Trieste, Italy, 6Cleveland Clinic, Cleveland, OH, USA.
9:04 a.m.-9:20 a.m.   DISCUSSION
9:20 a.m.-9:35 a.m.   STATE-OF-THE-ART: PROSTATE CANCER
Learning Robotic Prostatectomy
David S. Wang, MD
9:35 a.m.-9:50 a.m.   VIDEO: My Nerve Sparing Technique
Chair: Douglas M. Dahl, MD
Participants: Douglas M. Dahl, MD, Francis J. McGovern, MD, John J. Munoz, MD, Ingolf A. Tuerk, MD
9:50 a.m.-10:05 a.m.   What's New at my Institution
10:05 a.m.-10:30 a.m.   The Man in the Arena: The Urologist in 2007
Kevin R. Loughlin, MD
10:30 a.m.-10:40 a.m.   Presidential Address
A Need for Change in Urologic Education
W. Scott McDougal, M.D.
10:40 a.m.–11:05 a.m.   COFFEE BREAK – VISIT EXHIBITS
Cityview Ballroom
11:05 a.m.–12:40 p.m.   CONCURRENT SCIENTIFIC SESSION II: BPH
Amphitheater

Educational Objectives:
At the conclusion of this session the participants will be able to:
  • List the factors that contribute to the problem of nocturia
  • Describe the problems patients experience following laser prostatectomy
  • Describe the state of the art treatments for prostatic obstruction
11:05 a.m.   8. Age-Related Difference in Circadian Rhythm of Urine Output Under Constant Condition
John Hares, MD, Kevin R. Loughlin, MD, Van T. Nguygen, MD, Kenneth P. Wright, Jr., PhD, Charles A. Czeisler, PhD, Jeanne F. Duffy, MBA. PhD.
BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA, USA.
11:12 a.m.   9. Urinary Symptoms Are Related With Sleep Complaints and Daytime Sleepiness In Healthy Older People
Karine Scheuermaier, KEVIN R. LOUGHLIN, MD, MBA, Aaron Guzik, Jennifer Row, Mirjam Munch, Jeanne Duffy.
BRIGHAM AND WOMEN'S HOSPITAL, BOSTON, MA, USA.
11:19 a.m.   10. The Influence of Age and Initial Prostate Volume on the PSA Response to Testosterone Therapy
Stephen Lazarou, MD.
BIDMC, Brookline, MA, USA.
11:26 a.m.   11. Postoperative Problems of Patients Undergoing Greenlight Laser (Photoselective Vaporization of the Prostate) for Obstructive Benign Prostatic Hyperplasia
Michael R. Hermans, MD, King S. Coffield, MD.
Scott and White Clinic, Temple, TX, USA.
11:33 a.m.   12. KTP Laser Photoselective Vaporization of Prostate in Patients with Large-Volume Prostates
Brian Chapin, MD, Eisner Brian, MD, Susan Lahey, MD, Shahin Tabatabaei, MD.
Massachusetts General Hospital, Boston, MA, USA.
11:40 a.m.   13. A Head-To-Head Comparison of The Prolieve® System Vs. Targis® System For The Treatment Of BPH: Procedural Tolerability And Early Clinical Results
Neal Shore, MD1, Barrett Cowan, MD2, Parminder Sethi, MD3.
1Carolina Urologic Research Center, Myrtle Beach, SC, USA, 2Urology Associates, P.C., Denver, CO, USA, 3Valley Associated Urology Medical Group, Inc., Modesto, CA, USA.
11:47 a.m.   14. Multi-Center Prospective Randomized Double-Blind Study of Single-Injection Transrectal NX-1207 in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Neal D. Shore, MD1, Sheldon J. Freedman, MD2, Susan Jones Kalota, MD3, Barton H. Wachs, MD4, Barrett Edward Cowan, MD5, Kevin Cline, MD6.
1Carolina Urologic Research Center, Myrtle Beach, SC, USA, 2Sheldon J. Freedman MD, Ltd., Las Vegas, NV, USA, 3Arizona Urologic Specialists, Tucson, AZ, USA, 4Atlantic Urology Medical Group, Long Beach, CA, USA, 5Urology Associates, Denver, CO, USA, 6Regional Urology, LLC, Shreveport, LA, USA.
11:54 a.m.–12:10 p.m.   DISCUSSION
12:10 p.m.–12:25 p.m.   STATE-OF-THE-ART: BPH
Nocturia and When is a TURP Indicated
Richard K. Babayan, MD
12:25 p.m.-12:40 p.m.   VIDEO: My Laser Prostatectomy
Chair: Lori B. Lerner, MD
Participants: Lori B. Lerner, MD, Liam J. Hurley, MD, Michael R. Curtis, MD, Shahin Tabatabaei, MD
11:05 a.m.-12:15 p.m.   CONCURRENT POSTER SESSION I: BASIC SCIENCE
Harborview 1
Educational Objectives:
At the conclusion of this session the participants will be able to:
  • Describe Current areas of basic science research in the evaluation of urological disorders of the prostate , bladder and kidney
  • Describe the State of the art research techniques currently used in the evaluation of urological disorders of the prostate bladder and kidney
  • List the genes and growth Factors important in the development of urinary tumors
11:05 a.m.   VIEWING TIME
11:20 a.m.   P1. Prognostic Significance of Abnormal P-cadherin Expression in Transitional Cell Carcinoma of the Bladder
Gjanje L. Smith, M.D., Brasil S. Neto, M.D., Kimberly M. Rieger-Christ, Ph.D., Jessica A. Mandeville, M.D., Alex J. Vanni, M.D., John A. Libertino, M.D., Ian C. Summerhayes, Ph.D..
Lahey Clinic, Burlington, MA, USA.
11:23 a.m.   P2. P-cadherin is a Modulator of Migration Behavior in Bladder Carcinoma Cells
Jessica A. Mandeville, MD, Gjanje L. Smith, MD, Alex J. Vanni, MD, Kimberly M. Rieger-Christ, Ph.D., Brasil S. Neto, MD, John A. Libertino, MD, Ian C. Summerhayes, Ph.D..
Lahey Clinic, Burlington, MA, USA.
11:26 a.m.   P3. Establishment and Molecular Characterization of Immortalized Normal Urothelial Cell Lines: The Potential Role For RECK and GNE
Louis S. Liou, MD, PhD1, Ling Shen, MD2, Shi Yang, MD2, Gul Kirca, PhD2, Raymond Rackley, MD3, Joseph DiDonato, PhD3.
1Boston University, Milton, MA, USA, 2Boston University, Boston, MA, USA, 3Cleveland Clinic Foundation, Cleveland, OH, USA.
11:29 a.m.   P4. Differential Regulation of The Prostaglandin Pathway In A Mouse Model Of Bladder Cancer
John A. Taylor, III, MD, Olga Voznesensky, George A. Kuchel, MD, Carol Pilbeam, MD, PhD.
University of Connecticut, Farmington, CT, USA.
11:32 a.m.   P5. The Efficacy of a Novel Therapeutic Approach Targeting the Fibroblast Growth Factor Receptor in Bladder Carcinoma Cells using PD173074
Alex J. Vanni, M.D., Arthur Mourtzinos, M.D., Jessica Mandeville, M.D., Gjanje L. Smith, M.D., Kimberly M. Rieger-Christ, PhD, John A. Libertino, M.D., Ian C. Summerhayes, PhD.
Lahey Clinic, Burlington, MA, USA.
11:35 a.m.   P6. RNA-binding Protein IMP3 as A Novel Molecular Marker to Predict Metastasis and Progression of Renal Cell Carcinoma
Chin-Lee Wu, M.D., Ph.D.1, Zhong Jiang, M.D.2, Peiguo Chu, M.D.3, Qin Liu, Ph.D.2, Bruce A. Woda, M.D.2, Kenneth Rock, M.D.2, W. Scott McDougal, M.D.1.
1Massachusetts General Hospital, Boston, MA, USA, 2University of Masschusetts Medical Center, Worcester, MA, USA, 3City of Hope National Medical Center, Los Angeles, CA, USA.
11:38 a.m.   P7. Hypermethylation Of Genes In Clear Cell Carcinoma Of The Kidney And Correlation with Protein Expression
Gul Kirca, PhD1, Dustin Holloway, PhD1, Ja Sun Kang1, Ling Shen, MD1, Michelle Drever, BA1, Tara Williams, MD1, Thomas King, MD, PhD1, Charles Delisi1, Louis S. Liou, MD, PhD2.
1Boston University, Boston, MA, USA, 2Boston University, Milton, MA, USA.
11:41 a.m.   P8. MicroRNA Profiling of Clear Cell Kidney Cancer
David Juan, BA1, Travis Antes, BA2, Louis S. Liou, MD, PhD3.
1Boston University, Boston, MA, USA, 2System Biosciences, Mountain View, CA, USA, 3Boston University, Milton, MA, USA.
11:44 a.m.   P9. Stromally expressed c-Jun Regulates Proliferation of Prostate Epithelial Cells
Aria F. Olumi, M.D.1, Wenhua Li, PhD1, Phillip G. Febbo, M.D.2, Chin-Lee Wu, M.D., PhD.1.
1Massachusetts General Hospital, Boston, MA, USA, 2Duke University, Durham, NC, USA.
11:47 a.m.   P10. Gene Expression Signature Predicting Prostate Cancer Progression
Chin-Lee Wu, M.D., Ph.D.1, Xiao-Jun Ma, Ph.D.2, Eugene Cha, B.S.1, Dror Michaelson, M.D., Ph.D.1, Mark Erlander, Ph.D.2, W. Scott McDougal, M.D.1.
1Massachusetts General Hospital, Boston, MA, USA, 2AviaraDx, Inc., Carlsbad, CA, USA.
11:50 a.m.   P11. Heterogeneous Expression of TMPRSS2-ERG Gene Fusions in Human Prostate Cancers: Insights from a Prospective Prostate Biopsy Series
Michael C. Kearney1, Gary P. Kearney, MD2, Andrew L. Guerra1, Heather Conroe1, Gerardo Trejo1, Joanna Jung1, Gerri Bueti1, Jihad Hayek, MD2, Juan-Miguel Mosquera, MD3, Martin G. Sanda, MD1, Mark A. Rubin, MD3, Sandra M. Gaston, PhD1.
1BIDMC, Boston, MA, USA, 2NEBH, Boston, MA, USA, 3BWH, Boston, MA, USA.
11:53 a.m.   P12. ß-Catenin Mediates Alteration in Cell Proliferation, Motility and Invasion of Prostate Cancer Cells by Differential Expression of E-Cadherin and Protein Kinase D1
Viqar Syed, Ph.D, Paul Mak, Ph.D, Kethandapatti Balaji, MD.
University of Massachusetts Medical School, Worcester, MA, USA.
11:56 a.m.   P13. Metabolomic Imaging of Prostate Cancer
Chin-Lee Wu, M.D., Ph.D., Leo Cheng, Ph.D., Kate Jordan, B.S., W. Scott McDougal.
Massachusetts General Hospital, Boston, MA, USA.
11:59 a.m.-12:15 p.m.   DISCUSSION
12:15 p.m.-12:45 p.m.   COFFEE BREAK
12:45 p.m.–1:15 p.m.   TUMT, TURP, Laser TURP
PANEL
Amphitheater

Moderator: Robert A. Roth, MD
Panelists: Robert A. Roth, MD
Mark K. Plante, MD
Rochard K. Babayan, MD
Barry S. Stein, MD
Lori B. Lerner
1:15 p.m.-2:15 p.m.   LUNCH
1:15 p.m.-2:15 p.m.  
LUNCH SYMPOSIUM    Lunch Symposium: Advancing the Management of OAB: A Therapeutic Update

Advancing the Management of OAB: A Therapeutic Update

Faculty: David R. Staskin, MD
New York Presbyterian Hospital
Weill Cornell Medical College
New York, NY
Made possible by a grant from Esprit Pharma
2:15 p.m.-5:15 p.m.   AUA INSTRUCTIONAL COURSE
Amphitheater

Hot Topics in Coding
Stephanie Stinchcomb
5:30 p.m.-6:30 p.m.   RESIDENTS CASE PRESENTATIONS: Pre-Reception
Harborview 2
6:30 p.m.-8:00 p.m.   Boston's Freedom Trail Reception
Seaport Hotel, Lighthouse Ballroom
SATURDAY, SEPTEMBER 29, 2007
6:00 a.m.-7:50 a.m.   BREAKFAST SYMPOSIUM
Harborview 1
7:00 a.m.-1:30 p.m.   EXHIBIT HALL OPEN
Cityview Ballroom
7:00 a.m.   CONTINENTAL BREAKFAST - VISIT EXHIBITS
Cityview Ballroom
8:00 a.m.-9:30 a.m.   CONCURRENT SCIENTIFIC SESSION III: FEMALE UROLOGY/INCONTINENCE
Amphitheater

Educational Objectives:
At the conclusion of this session the participants will be able to:
  • Describe current areas of research in voiding dysfunction in women
  • Describe current medical and surgical treatment options for urinary dysfunction in women
  • List areas of controversy in the evaluation and management of voiding dysfunction
8:00 a.m.   15. Report from a Randomized, Placebo-Controlled Study Showing Significant Improvement in Urgency and Patient-Reported Outcomes In Overactive Bladder Patients Treated With Solifenacin
David Staskin, MD1, Roger Dmochowski, MD2, Scott Serels3, Allam Fakhoury, MD4.
1Cornell University, New York, NY, USA, 2Department of Urologic Surgery and Vanderbilt Continence Center, Nashville, TN, USA, 3Bladder Control Center of Norwalk, Norwalk, CT, USA, 4Astellas Pharma US, Inc, Deerfield, IL, USA.
8:07 a.m.   16. Solifenacin Treatment Reduces Symptoms of Overactive Bladder in Patients with Residual Urgency on Tolterodine Treatment: Results of the VERSUS Study
Sergio Forero-Schwanhaeuser, MD1, Michael B. Chancellor, MD2, Mickey M. Karram, MD3.
1GlaxoSmithKline, King of Prussia, PA, USA, 2University of Pittsburgh, Pittsburgh, PA, USA, 3Tri-State Urogynecology, Cincinnati, OH, USA.
8:14 a.m.   17. Trospium Chloride 60 Mg Once Daily Demonstrates Rapid Relief From Urinary Urgency, Frequency, And Urgency Urinary Incontinence When Compared With Placebo As Assessed Using The Overactive Bladder-Symptom Composite Score
David Staskin1, Norm Zinner, MD2, Peter Sand, MD3, Roger Dmochowski, MD4.
1New York Presbyterian Hospital, Weill-Cornell Medical College, New York, NY, USA, 2Western Clinical Research, Torrance, CA, USA, 3Evanston Continence Center, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA, 4Vanderbilt University School of Medicine, Nashville, TN, USA.
8:21 a.m.   18. Does Self Reproted Pad Use Following Pubovaginal Sling Surgery Accurately Reflect Patient Quality Of Life?
John T. Stoffel, MD, Gjanje Smith, MD, Arthur Mourtzinos, MD, John F. Bresette, MD.
Lahey Clinic, Burlington, MA, USA.
8:28 a.m.   19. Tension Free Transperineal Pelvic Floor Reconstruction by Trocar Guided Approach - 2 Year Analysis and Critique
Mitchell H. Bamberger, MD, MBA1, Andrea M. Pezzella, MD1, David M. Trifilio, PA-C2.
1Fallon Clinic, Worcester, MA, USA, 2St. Vincent Hospital, Worcester, MA, USA.
8:35 a.m.   20. Long-Term Durability of Nonsurgical Radiofrequency Collagen Denaturation for Treatment of Stress Urinary Incontinence
Rodney A. Appell, MD, FACS.
Baylor College of Medicine, Houston, TX, USA.
8:42 a.m.   21. Sexual Functioning In Patients With Interstitial Cystitis/Painful Bladder Syndrome
J. Curtis Nickel, MD, FRCS (C)1, Andrew Chen, MA2, George J. Wan, PhD, MPH3, Dana L. Creanga, PhD4.
1Kingston General Hospital, Kingston, ON, Canada, 2Ortho-McNeil Janssen Scientific Affairs, Raritan, NJ, USA, 3Ortho-McNeil Janssen Scientific Affairs, Titusville, NJ, USA, 4Statistical Consultant, Norwalk, CT, USA.
8:42 a.m.-9:00 a.m.   DISCUSSION
9:00 a.m.-9:15 a.m.   STATE-OF-THE-ART: FEMALE UROLOGY/INCONTINENCE
Understanding Randomized Trials of Medical therapy for Bladder Dysfunction
John T. Stoffel, MD
9:15 a.m.-9:30 a.m.   VIDEO: My Sling
Chair: E. Ann Gormley, MD
Participants: E. Ann Gormley, MD, John T. Stoffel, MD, Ron Yap, MD, Mary-Grey Maher, MD
8:00 a.m.-9:00 a.m.   CONCURRENT POSTER SESSION II: PEDIATRICS/PATIENT SAFETY
Harborview 1

Educational Objectives:
At the conclusion of this session the participants will be able to:
  • Describe current areas of research in Pediatric Urology
  • Describe State of the Art therapeutic options for managing patients with common and complex pediatric urological problems
  • List interventions to improve patient safety in the operating room
8:00 a.m.   VIEWING TIME
8:15 a.m.   P14. Terminal Differentiation of the Urinary Bladder Epithelium Occurs In A Specific Spatial and Temporal Pattern
Patricio C. Gargollo, MD, Sean Li, PhD.
Childrens Hospital Boston, Boston, MA, USA.
8:18 a.m.   P15. The Six1/Eya1 Transcription Complex Plays A Role in Perineal Patterning And Urorectal Septation in the Mouse Embryo
Patricio C. Gargollo, MD, Sean Li, PhD.
Childrens Hospital Boston, Boston, MA, USA.
8:21 a.m.   P16. Bladder Function after Bladder Neck Reconstruction in Complete Primary Repair of Bladder Exstrophy
Patricio C. Gargollo, MD, David A. Diamond, M.D., Joseph G. Borer, M.D..
Children's Hospital Boston, Boston, MA, USA.
8:24 a.m.   P17. Peri-Operative Risk Factors for Surgical Complications in Pediatric Urology
Drew A. Freilich1, Alan Retik, MD2, Hiep Nguyen, MD2.
1University of Massachusetts Medical School, Worcester, MA, USA, 2Children's Hospital Boston, Boston, MA, USA.
8:27 a.m.   P18. Patient Safety in the Operating Room
Bartley G. Cilento, Jr., MD, MPH1, Carlos Estrada, MD1, Meghan Dierks, MD2.
1Children's Hospital Boston, Boston, MA, USA, 2Beth Israel Deconess Hospital, Boston, MA, USA.
8:30 a.m.   P19. Closed Cockpit Bladder Evacuation: New Technology and its Evaluation
Mark K. Plante, MD, FRCS(C), FACS1, Mark R. Harvie, Engineering2, Sarah J. Parent, Psychology2.
1University of Vermont, Burlington, VT, USA, 2Omni Medical Systems, Inc., Burlington, VT, USA.
8:33 a.m.   P20. Comparing the Efficacy of Performing Pyeloplasty Using Open, Conventional and Robotic-Assisted Laparoscopic Techniques in an Animal Model.
Carlo C. Passerotti, MD, Ph.D, Ana Maria S. Passerotti, MD, Nikolai Begg, Jayanti Uberoi, MD, Alan B. Retik, MD, FAAP, Hiep T. Nguyen, MD, FAAP.
Harvard Medical School, Boston, MA, USA.
8:36 a.m.   P21. In utero Treatment for Bladder Outlet Obstruction Using Robotic-Assisted Laparoscopic Techniques
Hiep T. Nguyen, MD, FAAP, Carlo C. Passerotti, MD, Ph.D, Carol Barnewolt, MD, Valerie Ward, MD, Patricia Dunning, Jayanti Uberoi, MD, Jiang Xuewu, MD, Nikolai Begg, Alan B. Retik, MD, FAAP.
Harvard Medical School, Boston, MA, USA.
8:39 a,m.   P22. The Safety Profile of Trocar and Insufflation Needle Access Systems Used in Pediatric Laparoscopic Surgery
Hiep T. Nguyen, MD, FAAP, Carlo C. Passerotti, MD, Ph.D, Nikolai Begg, Ana Maria S. Passerotti, MD, Alan B. Retik, Sr., MD, FAAP.
Harvard Medical School, Boston, MA, USA.
8:42 a.m.-9:00 a.m.   DISCUSSION
9:30 a.m.-10:15 a.m.   PRESIDENTIAL PERSPECTIVES
Amphitheater

Controversies in Treating Patients Who Have A Rising PSA Following Definitive Treatment for Prostate Cancer
Paul F. Schellhammer, MD
Virginia Medical School
Norfolk, VA

The Natural History of a Rising PSA Following Radical Prostatectomy
W. Scott McDougal, MD

Massachusetts General Hospital
Boston, MA

10:15 a.m.-10:45 a.m.   COFFEE BREAK – VISIT EXHIBITS
Cityview Ballroom
10:45 a.m.-12:05 a.m.   CONCURRENT SCIENTIFIC SESSION IV: PEDIATRIC
Amphitheater

Educational Objectives:
At the conclusion of this session the participants will be able to:
  • Describe current areas of research in Pediatric Urology
  • Describe State of the Art therapeutic options for managing patients with common and complex pediatric urological problems
  • List current areas of controversy in the management of common problems including vesicoureteral reflux, hydronephrosis and hypospadias
10:45 a.m.   22. Prospective Follow-Up of Patients after Complete Primary Repair of Bladder Exstrophy
Patricio C. Gargollo, MD, Joseph G. Borer, M.D., David A. Diamond, M.D., W. Hardy Hendren, M.D., Ilina Rosoklija, MPH, Rosemary Grant, RN, Alan B. Retik, M.D..
Children's Hospital Boston, Boston, MA, USA.
10:52 a.m.   23. The Predictive Value of the First Postnatal Ultrasound in a Cohort of 1441 Children with Prenatally Diagnosed Hydronephrosis
Hiep T. Nguyen, MD, FAAP, Carlo C. Passerotti, MD, Ph.D, Marc Cendron, MD, FAAP, Leslie Kalish, Scd, Ana Maria S. Passerotti, MD, Andres Silva, MD, Pedro Recabal, MD, Jeanne Chow, MD, Richard S. Lee, MD, Alan B. Retik, Sr., MD, FAAP.
Harvard Medical School, Boston, MA, USA.
10:59 a.m.   24. Extracorporeal Shock Wave Lithotripsy in Pediatric Patients Using a Late-Generation Lithotriptor: Experience at Children’s Hospital Boston
Caleb P. Nelson, MD, MPH, David A. Diamond, MD, Bartley G. Cilento, MD, MPH.
Children's Hospital Boston, Boston, MA, USA.
11:06 a.m.   25. Varicocele Surgery: Institutional Experience with Four Techniques
David A. Diamond, M.D., Jiang Xuewu, M.D., Bartley G. Cilento, Jr., M.D., Stuart B. Bauer, M.D., Craig A. Peters, M.D., Joseph G. Borer, M.D., James Mandell, M.D., Marc Cendron, M.D., David Zurakowski, Ph.D., Ilina Rosoklija, M.P.H., Alan B. Retik, M.D..
Children's Hospital, Boston, MA, USA.
11:13 a.m.   26. Bilateral Undescended Testes: Is Anatomic Location Symmetric?
David A. Diamond, M.D., Hiep T. Nguyen, M.D., Carlo Passerotti, M.D.
Children's Hospital, Boston, MA, USA.
11:20 a.m.   27. Prophylactic Antibiotic Cessation Is Safe in Toilet Trained Children With Vesicoureteral Reflux With Adequately Treated Dysfunctional Elimination Syndrome
Daniel B. Herz, M.D., Paul A. Merguerian, M.D., Christine Danielson, P.N.P., Mary Gheen, P.N.P.
Children's Hospital at Dartmouth / Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
11:20 a.m.-11:35 a.m.   DISCUSSION
11:35 a.m.-11:50 a.m.   STATE-OF-THE-ART: PEDIATRIC
An Adult Urologist Perspective on Pediatric Varicoele

Mark Sigman, MD
11:50 a.m.-12:05 a.m.   VIDEO: Reflux-Deflux, What’s a Urologist to do?
Chair:Dan Herz
Participants:David A. Diamond, MD
Anthony A. Caldamone, MD
George Klauder, MD
Paul A. Merguerian, MD
10:45 a.m.-11:40 a.m.   CONCURRENT POSTER SESSION III: GENERAL UROLOGY
Harborview 1

Educational Objectives:
At the conclusion of this session the participants will be able to:
  • Describe current areas of research in bladder and kidney cancer
  • Describe state of the art therapeutic options for erectile dysfunction
  • List areas of controversy in the management of the infertile male
10:45 a.m.   VIEWING TIME
11:00 a.m.   P23. Preliminary Observations of a Novel Intravascular Hemostatic Tool for Partial Nephrectomy
Alex J. Vanni*, M.D.1, Jessica Mandeville*, M.D.1, Gjanje L. Smith*, M.D.1, Jean-Marie Vogel, ABD2, James Wilkie, BS3, John A. Libertino, M.D.1, Peter Madras, M.D.1.
1Lahey Clinic, Burlington, MA, USA, 2Pluromed Inc, Woburn, MA, USA, 3Pluromed, Woburn, MA, USA.
11:03 a.m.   P24. Trends of the Histopathology of Renal Masses in A Contemporary Cohort
Edward G. Myer, MD1, Benkang Shi2, Ilene Staff2, Steven J. Shichman, M.D.2.
1University of Connecticut, Farmington, CT, USA, 2Hartford Hospital, Hartford, CT, USA.
11:06 a.m.   P25. Regulatory T Cells in Patients with Metastatic Renal Cell Carcinoma (RCC) Treated with Immunotherapy - Key to Failure or Success of Treatment?
Adrian Schwarzer, MD, Thomas Schwaab, MD PhD, Jan Fisher, MD, Cathy Foster, MD, John Seigne, MD, Marc Ernstoff, MD.
Concord Hospital, Concord, NH, USA.
11:09 a.m.   P26. Intravesical Gemcitabine for Treatment of BCG Resistant High-Risk Transitional Cell Carcinoma
Egbert D. Baumgart, MD1, Michael Callum, MD2, Micah A. Jacobs, MD1, Chad Wotkowicz, MD1, John A. Libertino, MD1.
1Lahey Clinic, Burlington, MA, USA, 2North Shore Medical Center, Salem, MA, USA.
11:12 a.m.   P27. Updated Outcomes with Coordinated Chemoradiation Therapy as the Primary Treatment for Invasive Carcinoma of the Male Urethra
Michael S. Cohen, MD1, Veronica Triaca, MD2, Brian Billmeyer, MD1, Robert S. Hanley, MD1, Lyubov Girshovich, MD1, Todd Shuster, MD1, Richard A. Oberfield, MD1, Leonard Zinman, MD1.
1Lahey Clinic Medical Center, Burlington, MA, USA, 2UCLA Medical Center, Los Angeles, CA, USA.
11:15 a.m.   P28. Prevalence of Osteopenia in a Population of Infertile Men
Daniel M. Kaplon, MD, Mark Sigman, M.D..
Brown University, Providence, RI, USA.
11:18 a.m.   P29. Efficacy of Sildenafil Citrate At 8 And 12 Hours Postdose In Men With Mild To Moderate Erectile Dysfunction
Evan R. Goldfischer, MD1, Andrew R. McCullough, MD, FACS2, Christopher P. Steidle, MD3, Brian Klee, MD4, Li-Jung Tseng, PhD4.
1Hudson Valley Urology, P.C., Poughkeepsie, NY, USA, 2New York University School of Medicine, New York, NY, USA, 3Northeast Indiana Urology, PC, Fort Wayne, IN, USA, 4Pfizer Inc, New York, NY, USA.
11:21 a.m.   P30. Comparison of Outcomes in Vasovasostomy Performed in the Convoluted and Straight Vas Deferens
Sutchin R. Patel, M.D., Mark Sigman, M.D..
Brown Medical School, Providence, RI, USA.
11:24 a.m.   P31. Long Term Outcomes of Penile Revascularization Surgery Using Validated Questionnaires
Chester C. Lee, MD, Jayant Uberoi, MD, Ricardo Munarriz, MD.
Boston Medical Center, Boston, MA, USA.
11:24 a.m.-11:40 a.m.   DISCUSSION
12:05 p.m.-1:00 p.m.   ANNUAL BUSINESS MEETING
12:30 p.m.-2:00 p.m.  
LUNCH SYMPOSIUM
Harborview 1
   Lunch Symposium: The Impact of Low Testosterone on Clinical Well-Being in the Male Patient

The Impact of Low Testosterone on Clinical Well-Being in the Male Patient

Faculty: Andrew R. McCullough, MD, FACS
Associate Professor
New York University School of Medicine
New York, New York
Made possible by a grant from Auxilium Pharmaceutical
2:00 p.m.-2:30 p.m.   INVITED GUEST SPEAKER
Recent Advances in Medical Therapy of Advanced Renal Cancer
Michael B. Atkins, MD
Beth Israel Deaconess Medical Center, Boston, MA
2:30 p.m.   INTRODUCTION OF WYLAND F. LEADBETTER MEMORIAL LECTURER
Who Was Wyland F. Leadbetter?

W. Scott McDougal, MD
2:35 p.m.-3:20 p.m.   WYLAND F. LEADBETTER MEMORIAL LECTURER
Stephen P. Dretler, MD.
Massachusetts General Hospital
Boston, Massachusetts
3:20 p.m. – 5:10 p.m.   CONCURRENTSCIENTIFIC SESSION V: STONE/ENDOUROLOGY
Amphitheater

Educational Objectives:
At the conclusion of this session the participants will be able to:
  • Describe the role of inhibitors of crystallization in stone prevention
  • Discuss imaging techniques to assess stone risk
  • Describe new technologies in stent development
3:20 p.m.   28. Assessment of Citrate Concentrations in Citrus Fruit-Based Juices and Beverages: Implications for Management of Hypocitraturic Nephrolithiasis
George E. Haleblian, M.D.1, Victor A. Leitao, M.D.2, David M. Albala, M.D.3, Anthony A. Riberio, PhD4, Glenn M. Preminger, M.D.2.
1Brown Universtiy School of Medicine, Providence, RI, USA, 2Duke Universtiy Medical Center, Durham, NC, USA, 3Duke Universtiy School of Medicine, Durham, NC, USA, 4Duke Universtiy, Durham, NC, USA.
3:27 p.m.   29. Induction of Hypocitraturia and Development of Urolithiasis By Topiramate
Brad W. Warner, MD, Tarvez Tucker, MD, Vernon M. Pais, Jr., MD.
University of Kentucky, Lexington, KY, USA.
3:34 p.m.   30. In Vitro Urine Flow Rate and Encrustation Properties of A Non-Tubular Ureteral Stent with A Novel Configuration
Chester Lee, MD, Jayant Uberoi, MD, Richard K. Babayan, MD, David S. Wang, MD.
BOSTON UNIVERSITY MEDICAL CENTER, BOSTON, MA, USA.
3:41 p.m.   31. Differences in Computed Tomography Density of the Renal Papillae of Stone Formers and Non-Stone Formers: A Pilot Study
Brian H. Eisner, MD, Ahsan Iqbal, BA, Saravanan Namasivayam, MD, Onofrio Catalano, MD, Stephen P. Dretler, MD, Dushyant V. Sahani, MD.
Massachusetts General Hospital, Boston, MA, USA.
3:48 p.m.   32. A Novel Method of Imaging Urolithiasis Using Fluorescence Probes
Hiep T. Nguyen, MD, FAAP, Carlo C. Passerotti, MD, Ph.D, Jose Luiz Figueiredo, MD, Ralph Weissleder, MD.
Harvard Medical School, Boston, MA, USA.
3:55 p.m.   33. Ureteral Stone Size and Location: Impact on Ureteral Dilation
Brian H. Eisner, MD1, Renato N. Pedro, MD2, Saravanan Namasivayam, MD1, Dushyant V. Sahani, MD1, Stephen P. Dretler, MD1, Manoj Monga, MD2.
1Massachusetts General Hospital, Boston, MA, USA, 2University of Minnesota, Minneapolis, MN, USA.
4:02 p.m.   34. Appearance of Uric Acid Calculi on Computed Tomography Scout Films
Brian H. Eisner, MD1, Christopher Cutie, MD2, Onofrio A. Catalano, MD1, Edwin L. Prien, Jr., MD1, Stephen P. Dretler, MD1, Dushyant V. Sahani, MD1.
1Massachusetts General Hospital, Boston, MA, USA, 2 Department of Urology, Massachusetts General Hospital, Harvard Medical School.
4:09 p.m.-4:25 p.m.   DISCUSSION
4:25 p.m.-4:40 p.m.   STATE-OF-THE-ART: STONE/ENDOUROLOGY
Surgical Management

Gyan Pareek, MD

Medical/Metabolic Management
Gary Curhan, MD

4:40 p.m.-4:55 p.m.   VIDEO: My Favorite Gizmo
Chair:Stephen P. Dretler, MD
Participants:Stephen P. Dretler, MD
John A. Libertino, MD
David S. Wang, MD
Hiep Nguyen, MD
3:20 p.m. – 4:15 p.m.   CONCURRENT POSTER SESSION IV: PROSTATE CANCER
Harborview 1

Educational Objectives:
At the conclusion of this session the participants will be able to:
  • Describe the current areas of clinical research in prostate cancer
  • Describe innovative surgical procedures in the management of prostate cancer using laparoscopic techniques
  • List current area of controversy in the management of patients with prostate cancer
3:20 p.m.   VIEWING TIME
3:35 p.m.   P32. Impact of Radical Prostatectomy Positive Surgical Margins on Fear of Cancer Recurrence: Results from CaPSURE
Y. Mark Hong, M.D.1, Jim C. Hu, MD, MPH1, Alan T. Paciorek, BS2, Sara J. Knight, PhD2, Peter R. Carroll, MD2.
1Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA, 2University of California San Francisco, San Francisco, CA, USA.
3:38 p.m.   P33. Correlation Between the International Prostate Symptom Score, Prostate Specific Antigen, and Quality of Life Findings in a Screening Population
Barry S. Stein, MD, MBA, Dean E. Leocádio, MD, MA, Michael Schwartz, MD.
Rhode Island Hospital, Providence, RI, USA.
3:41 p.m.   P34. Salvage Prostate Cryoablation: Results from the COLD Registry
John P. Long, MD1, Louis L. Pisters, MD2, Aaron E. Katz, MD3, John C. Rewcastle, PhD4, Bryan J. Donnelly, MD4, Franco M. Lugnani, MD5, J. Stephen Jones, MD6.
1New England Urology, Framingham, MA, USA, 2MD Anderson Cancer Center, Houston, TX, USA, 3Columbia University, New York, NY, USA, 4University of Calgary, Calgary, AB, Canada, 5Society for Cryosurgery, Trieste, Italy, 6The Cleveland Clinic, Cleveland, OH, USA.
3:44 p.m.   P35. Focal and Nerve Warming Cryoablation: Results from the COLD Registry
Stephen M. Scionti, MD1, Louis L. Pisters, MD2, Aaron E. Katz, MD3, Franco M. Lugnani, MD4, Bryan J. Donnelly, MD5, John C. Rewcastle, PhD5, J. Stephen Jones6.
1CryoCare Center, Hilton Head, SC, USA, 2MD Anderson Cancer Center, Houston, TX, USA, 3Columbia University, New York, NY, USA, 4Society for Cryosurgery, Trieste, Italy, 5University of Calgary, Calgary, AB, Canada, 6Cleveland Clinic, Cleveland, OH, USA.
3:47 p.m.   P36. Randomized Trial of Active Cellular Immunotherapy with Sipuleucel-T in Androgen Dependent Prostate Cancer (ADPC)
Karim J. Hamawy, M.D.1, Mark W. Frohlich, M.D.2.
1Lahey Clinic, Burlington, MA, USA, 2Dendreon Corporation, Seattle, WA, USA.
3:50 p.m.   P37. Autologous Intranodal Dendritic Cell Vaccine in Patients with Metastatic Renal Cell Carcinoma (RCC)-The Secret to Long-Lasting Clinical Responses?
Thomas Schwaab, MD PhD, Adrian Schwarzer, MD, Jan Fisher, MD, John Seigne, MD, Marc Ernstoff, MD.
Concord Hospital, Concord, NH, USA.
3:53 p.m.-4:15 p.m.   DISCUSSION
7:00 p.m.   PRESIDENT’S RECEPTION AND BANQUET: ODYSSEY CRUISE
7:00 p.m.-8:00 p.m.   Board Boats
8:00 p.m.-11:00 p.m.   Cruise